Pharma podcast production: scientific authority in a regulated industry.
Policy voice, market access credibility, and industry standing, produced on a schedule that plans for review instead of colliding with it.
Resonate Recordings leverages 12 years of industry experience to produce professional B2B pharma and biotech podcasts that prioritize scientific credibility, policy influence, and industry relationships. Our process is built for high-stakes environments, ensuring that expert thought leadership can flourish within your organization's own review requirements.
We understand that in this sector, a podcast isn't just content. It's a way to shape the conversation on access and affordability, and a platform to put your scientific and policy expertise in front of the people who set the agenda.
Trusted by enterprise and pharma-adjacent brands
The companies behind shows we have produced.
High-stakes pharma media production.
While most agencies treat regulatory review as somebody else's problem to solve after the recording is done, Resonate provides the production infrastructure that lets your organization publish with scientific authority. We specialize in building the technical foundation for professional pharma and biotech podcasts, ensuring your team has the tools and the timeline to maintain total control over its own review requirements.
The Framework for Scientific Authority
Our work on Prescription for Better Access, an ongoing show for the pharma and market access industry, is proof of our specialized discipline in supporting this sector.
By integrating our production process with your internal MLR workflows, we empower your medical, legal, and regulatory teams to review every detail before an episode reaches the public. We don't just offer a "check" at the end. We provide a production environment and a release schedule that accounts for real review cycles, allowing your scientific and policy voice to flourish while you maintain the ultimate responsibility for regulatory standards and promotional compliance.
Book a Strategy Call →typical MLR review timeline per content piece at mid-to-large pharma companies.
Prescription for Better Access has run continuously since 2023 for the pharma and market access industry.
producing podcasts for enterprise, regulated, and life sciences clients since 2014.
across 3,000+ podcasts launched, giving your show a team that has done this before.
What kind of show fits your organization?
Format choice usually comes down to which audience you need and how your own review process treats each type of content. We help you pick one your team can actually sustain.
Policy & Market Access Shows
Cover drug pricing, PBMs, and affordability policy. This is the exact format behind Prescription for Better Access, and it puts your organization into the access conversation rather than talking around it.
Scientific Storytelling
Feature researchers and R&D teams discussing the science behind a therapeutic area. A scientific storytelling show builds standing with clinicians, investigators, and scientific media.
Medical Affairs & Industry Commentary
A recurring show for medical affairs teams and business development audiences tracking industry trends, policy shifts, and the competitive landscape.
Internal & R&D Communications
Private, restricted-access shows for scientific teams and internal updates across sites and functions, distributed the same way a public show would be but only to the people it is meant for.
Build the package that fits your organization. One production partner.
These are the services your show can be built from. Take the full stack, or pick only the pieces you need. Either way it stays with one team, with your review windows written into the schedule rather than discovered mid-production.
Podcast Launch
End-to-end launch that maps your internal review timeline into the production schedule from day one, so a long review cycle isn't a surprise before your first episode airs.
Learn moreAudio Production
Professional editing, mixing, and mastering for every episode. Degree-trained engineers, three to five business day turnaround, and a consistent process for a long-running show like Prescription for Better Access.
Learn moreVideo Production
YouTube-ready video cuts and short-form clips from every recording, delivered through the same review workflow as your audio episodes so nothing publishes ahead of your sign-off.
Learn morePodcast Management
A dedicated producer manages your show week to week, including scheduling around review submission windows and medical affairs calendars instead of working against them.
Learn morePodcast Marketing
Audiograms, videograms, and full episode transcripts from every recording, ready for your team to route through review before publishing. Transcripts also make your show readable to search and AI answer engines, which audio alone never is.
Learn morePrivate & Public Hosting
Public distribution to Apple, Spotify, and YouTube for industry-facing shows, or private, restricted-access hosting for internal medical affairs and R&D communication.
Learn morePrescription for Better Access, produced episode after episode.
Prescription for Better Access is co-hosted by Mark Hansan and Dr. Scott Howell, two industry veterans covering drug pricing, PBMs, patient access, and FDA policy for pharma, biotech, and market access audiences. Resonate has produced the show continuously since its 2023 launch, including live episodes recorded at industry events like Asembia's AXS Summit.
Book a Strategy Call →With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs, two industry veterans have joined forces to co-host an interview-focused podcast to help shape the future of patient access and affordability.
Pharma, policy, and enterprise podcasts produced by Resonate.
A real, ongoing pharma industry client, alongside practitioner and enterprise formats that translate to medical affairs and R&D audiences.
Prescription for Better Access
A recurring interview show co-hosted by Mark Hansan and Dr. Scott Howell, covering drug pricing, PBMs, patient access, and FDA policy for a pharma and biotech industry audience. Produced by Resonate since its 2023 launch.
This is Resonate's clearest pharma-vertical credential: a real, ongoing client show built for exactly the policy and market access audience this page is written for.
Listen on Apple Podcasts →Shared Practices, Your Dental Roadmap
A practitioner-focused show for dental professionals navigating practice ownership, growth, and transition. Produced by Resonate since launch, the show has built a loyal, returning audience within its niche.
Pharma and biotech teams can use this same practitioner-deep-dive format to build credibility with a clinical or scientific audience over time.
Listen on Apple Podcasts →Better by Great Place to Work
A branded podcast for Great Place to Work, the global authority on workplace culture, interviewing executives and people leaders on building high-trust workplaces. Produced and managed end-to-end by Resonate.
Pharma and biotech organizations can use this same internal-communications model for R&D team storytelling and employee-facing content.
Listen on Apple Podcasts →Ready to build a show your review team can plan around?
Thirty minutes. We discuss your audience, your internal review process, and what a production schedule looks like for your organization.
Common questions about pharma and biotech podcast production.
Everything you need to know before starting or scaling a podcast for your organization.
Book a Strategy Call →What is a pharma or biotech podcast?+
How does MLR review affect a pharma podcast schedule?+
What does a pharma podcast production agency do?+
Who is responsible for regulatory compliance on a pharma podcast?+
What kind of podcast should a pharma or biotech company launch?+
How much does pharma podcast production cost?+
How is a pharma podcast different from a general branded podcast?+
Has Resonate produced podcasts for pharma or biotech organizations specifically?+
The access conversation is happening without you.
Let's build a show that puts you in it.
Book a thirty-minute strategy call. We discuss your audience, your internal review process, and what a pharma podcast looks like for your organization.
No commitment. Thirty minutes. Honest advice about whether podcasting is right for your organization right now.